Skip to content

The language connectome of brain tumor patients

The language connectome of brain tumor patients - Language Connectome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00026720
Enrollment
300
Registered
2021-10-19
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71

Interventions

Group 1: Patients MRi, neuropsychological assessment & statistical analysis Group 2: Subjects receive a one-time neuropsychological test for a one-time MRT

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 200 Years

Inclusion criteria

Inclusion criteria: Glioma left hemisphere (WHO i-IV)

Exclusion criteria

Exclusion criteria: Any history of neurologic or psychiatric illness, Left-handedness, MRI incompatibility.

Design outcomes

Primary

MeasureTime frame
The impact of the tumour on the language network will be measured using statistical machine learning models, probably by the end of 2024. What: Tumours in the language area; When: 2021-2024; How: Neuropsychological testing (AAT, NIHSS, DEMTECT, BN20, EHI) and advanced neuroimaging (dMRI, rsfMRI, T1, T2, MPM in subjects 1x each, in patients immediately before and up to 7 days after surgery.

Secondary

MeasureTime frame
By the end of 2024, further correlations of variables will be taken into account in the statistical model

Countries

Germany

Contacts

Public ContactLucius Fekonja

Charité - Universitätsmedizin Berlin;Cluster of Excellence, Matters of Activity, Humboldt-Universität zu Berlin

lucius.fekonja@charite.de030450660745

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026